Sanas SRL
Sanas reported total assets of 698,330 € at the end of the 2025 financial year (annual accounts filed with the NBB on 01 Sep 2026).
The score of Sanas shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -53 % Total assets -30 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sanas's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −69,601 € | ||||
| Equity | 362,620 € | ||||
| Cash | 50,454 € | ||||
| EBITDA | −26,816 € | ||||
| Total assets | 698,330 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Sep 2026
- Year ended 31 Dec 2024filed on 24 Oct 2025
- Year ended 31 Dec 2023filed on 18 Sep 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 11 Jul 2022
Sanas's financial analysis
- Solvency51.9%sector median: 50.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sanas
Sanas's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0427.676.859
- VAT number
- BE0427676859
- Peppol
- Registered · 0208:0427676859 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Aug 1985
- Registered office
- 8530 Harelbeke
- Latest accounts
- 2025 · filed on 01 Sep 2026
- Activity
- Manufacture of other pharmaceutical products (NACE 21209)
Sanas (SRL) has been based in Harelbeke since 1985, active in: manufacture of other pharmaceutical products. For 2025, it reports a net loss of 69,601 € and equity of 362,620 €; its revenue is not published. Its solvency stands at 51.9%, above the median of its sector (50.3%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Sanas
Companies in the same business, of comparable size and area, outside its group.
- Highstar Engineering Manufacture of pharmaceutical preparations Diepenbeek · balance sheet 342,212 €
- GRNR Invest Manufacture of basic pharmaceutical products Zemst · balance sheet €2.26m
- Groupe Tete Pharmaceutical Manufacture of basic pharmaceutical products Nivelles · balance sheet €1.15m
- Efrax Manufacture of pharmaceutical preparations Brasschaat · balance sheet 577,651 €
- FASE Manufacture of pharmaceutical preparations Nazareth-De Pinte · balance sheet €2.45m
- Equibor Manufacture of basic pharmaceutical products Manage · balance sheet €1.12m
- Orca Consulting Manufacture of pharmaceutical preparations Kapellen · balance sheet 347,741 €
- Apotheek Pierlet Retail sale of pharmaceutical products Riemst · balance sheet 891,395 €
Frequently asked questions about Sanas
What is the revenue of Sanas?
Sanas files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sanas?
In Belgium, the VAT number is the company number prefixed with BE: BE0427676859 for Sanas, if the company is VAT-registered. Its company number (CBE) is 0427.676.859.
Where is the registered office of Sanas?
According to the CBE register, the registered office of Sanas is in 8530 Harelbeke.
What is the equity of Sanas?
At the close of the 2025 financial year, the equity of Sanas amounts to 362,620 €, a solvency of 51.9% of total assets.
Who manages Sanas?
The register lists 2 active mandates at Sanas. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sanas
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →